S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

SXTP 60 Degrees Pharmaceuticals Inc

0.848

0.02 (2.42%)

Jan 21 2025 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

60 Degrees Pharmaceuticals (NASDAQ:SXTP)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more 60 Degrees Pharmaceuticals Charts.

60 Degrees Pharmaceuticals (NASDAQ:SXTP)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more 60 Degrees Pharmaceuticals Charts.

60 Degrees Pharmaceuticals Inc News

60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. microti) Babesiosis
Wednesday 8 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention
Monday 23 December 2024 (4 weeks ago) • GlobeNewswire Inc.

60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital
Wednesday 11 December 2024 (1 month ago) • GlobeNewswire Inc.

60 Degrees Pharmaceuticals Announces Third Quarter 2024 Results
Thursday 14 November 2024 (2 months ago) • GlobeNewswire Inc.

60 Degrees Pharmaceuticals Inc. Announces ARAKODA® Promotional Pilot in Advance of Expanded U.S. Launch
Thursday 3 October 2024 (4 months ago) • GlobeNewswire Inc.

60 Degrees Pharmaceuticals, Inc. Announces Closing of $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Friday 6 September 2024 (5 months ago) • GlobeNewswire Inc.

60 Degrees Pharmaceuticals, Inc. Announces $4 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Wednesday 4 September 2024 (5 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 28 August 2024 (5 months ago) • Edgar (US Regulatory)

60 Degrees Pharmaceuticals, Inc. Regains Compliance with Nasdaq Listing Requirements
Wednesday 28 August 2024 (5 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 14 August 2024 (5 months ago) • Edgar (US Regulatory)

60 Degrees Pharmaceuticals Announces Second Quarter 2024 Results
Wednesday 14 August 2024 (5 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (5 months ago) • Edgar (US Regulatory)

More 60 Degrees Pharmaceuticals Inc News Articles

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions